Save the date for P4C 2013: November 3-5, New York City

2012 Confirmed Speakers

We will update our speaker list on a regular basis; please check back soon to see more distinguished speakers.

Quick Links:

A ∧ up

Labeeb Abboud, J.D.
Senior Vice President and General Counsel, International AIDS Vaccine Initiative

Margaret Anderson
Executive Director, FasterCures/The Center for Accelerating Medical Solutions

B ∧ up

Ramsey Baghdadi
Managing Editor, The RPM Report

Rashmi Barbhaiya, Ph.D.
Chief Executive Officer and Managing Director, Advinus Therapeutics

Anna Barker, Ph.D.
Director, Transformative Healthcare Networks, Co-Director, Complex Adaptive Systems Initiative and Professor, School of Life Sciences, Arizona State University

Eileen Bartholomew
Senior Director, Life Sciences, X PRIZE Foundation

Robert J. Beall, Ph.D.
President and CEO, Cystic Fibrosis Foundation

Michael Beckloff
President, Beckloff Associates, Inc.

Gordon R. Bernard, M.D.
Professor of Medicine, Associate Vice Chancellor for Research, and Senior Associate Dean for Clinical Science, Vanderbilt University

Leon Black
Co-Founder, Melanoma Research Alliance, Board Member, FasterCures, CEO, Apollo Management LP

Enriqueta (Queta) Bond , Ph.D.
Partner, QE Philanthropic Advisors

Jeffrey Brewer
President and CEO, Juvenile Diabetes Research Foundation

Timothy N. Bullock, Ph.D.
Associate Professor, Department of Pathology Human Immune Therapy Center, University of Virginia

Brook Byers
Partner, Kleiner Perkins Caufield & Byers

Maureen Byrnes
Former Executive Director of the National Commission on AIDS

C ∧ up

Michael Cembalest
Global Head of Investment Strategy, J.P. Morgan

Timothy Coetzee, Ph.D.
Chief Research Officer, National Multiple Sclerosis Society

Ron Cohen, M.D.
President and Chief Executive Officer, Acorda Therapeutics, Inc

N. Anthony Coles, M.D., MPH
President, Chief Executive Officer and Member of the Board, Onyx Pharmaceuticals

Anthony Coyle, Ph.D.
Vice President and CSO, Centers for Therapeutic Innovation, Pfizer, Inc.

Jason Cummins
Chief U.S. Economist and Head of Research, Brevan Howard Inc

D ∧ up

Louis DeGennaro, Ph. D.
Chief Mission Officer, Leukemia & Lymphoma Society

Susan Desmond-Hellmann, M.D., MPH
Chancellor, University of California, San Francisco

Ross C. DeVol
Chief Research Officer, Milken Institute

Susan Wolf Ditkoff
Partner, The Bridgespan Group

E ∧ up

Aled M. Edwards, Ph.D.
Chief Executive, Structural Genomics Consortium

F ∧ up

Howard Fillit, M.D.
Executive Director, Alzheimer's Drug Discovery Foundation

Garret FitzGerald, M.D., M.Sc.
Robert L. McNeil, Jr., Professor in Translational Medicine and Therapeutics, University of Pennsylvania

Valentina Fossati, Ph.D.
New York Stem Cell Foundation - Helmsley Investigator, The New York Stem Cell Foundation Laboratory

Stephen Friend, M.D., Ph.D.
President, Sage Bionetworks

G ∧ up

Brent Gendleman
President and Chief Executive Officer, 5AM Solutions

Kathy Giusti, MBA
Founder and Chief Executive Officer, Multiple Myeloma Research Foundation

George Golumbeski, Ph.D.
Senior Vice President of Business Development, Celgene Corporation

James C. Greenwood
President and CEO, Biotechnology Industry Organization (BIO)

H ∧ up

Margaret A. Hamburg, M.D.
Commissioner, U.S. Food and Drug Administration

Paula Hammond, Ph.D.
Bayer Chair Professor of Chemical Engineering, Massachusetts Institute of Technology

Brian Harvey, M.D., Ph.D.
Vice President, U.S. Regulatory Policy, Sanofi

Katie Hood, M.B.A.
Senior Fellow and Visiting Lecturer, Hart Leadership Program at Duke University's Sanford School of Public Policy

Kathy Hudson, Ph.D.
Deputy Director for Science, Outreach, and Policy, National Institutes of Health

Hoyoung Huh , M.D., Ph.D.
Chairman of the Board, Geron Corporation

I ∧ up

Thomas R. Insel, M.D.
Director, National Institute of Mental Health (NIMH), National Institutes of Health

J ∧ up

Kris Joshi , Ph.D.
Global Vice President - Healthcare, Oracle

K ∧ up

Thomas Kalil
Deputy Director for Policy, White House Office of Science and Technology Policy

Regis B. Kelly, Ph.D.
Director, The California Institute for Quantitative Biosciences (QB3), University of California

Annette Kleiser
Senior Program Officer, Industry Alliances, University of Southern California Stevens Institute

Annette Kleiser, Ph.D.
Senior Program Officer, Industry Initiatives, USC Stevens Institute for Innovation, University of Southern California

Fernando Kreutz, M.D., Ph.D.
Founder and President, FK-Biotec

L ∧ up

Warren B. Lammert
Chairman and Co-Founder, The Epilepsy Therapy Project

Peter Lansbury, Jr., Ph.D.
Chief Scientific Officer, LINK Medicine and Professor of Neurology, Harvard Medical School

Debra R. Lappin
President, Council for American Medical Innovation; Senior Vice President, B&D Consulting

Daniel Laster, J.D.
General Counsel, Legal Affairs, PATH

Jonathan Leff
Managing Director, Healthcare, Warburg Pincus

Susan Love, M.D.
President and Medical Director, Dr. Susan Love Research Foundation

M ∧ up

Michael Manganiello
Partner, HCM Strategists

David M. Margulies, M.D.
Senior Associate in Medicine and Director of The Gene Partnership (TGP), Children's Hospital Boston

James McCullough, MBA
Chief Executive Officer, Exosome Diagnostics, Inc.

Gerald McDougall
Principal, Personalized Medicine and Health Sciences Practices,PricewaterhouseCoopers

Teri Melese, Ph.D.
Associate Professor of Medicine and Director of Research Technologies and Alliances, School of Medicine, Dean's Office, University of California, San Francisco

Gwen A. Melincoff
Senior Vice President, Business Development, Strategic Investment Group, Shire Pharmaceuticals

John Mendlein, Ph.D., J.D.
Executive Chairman, Fate Therapeutics and Chairman, aTyr Pharma

Michael Milken
Chairman, Milken Institute and Chairman, FasterCures

Lesa Mitchell
Vice President, Ewing Marion Kauffman Foundation

Chris Morrison
Editor-in-Chief, Biopharmaceuticals and Consumer Products at Elsevier Business Intelligence

N ∧ up

Larry A. Nagahara, Ph.D.
Acting Director, Office of Physical Sciences-Oncology, National Cancer Institute

Garry Neil, M.D.
Corporate Vice President, Corporate Office of Science and Technology, Johnson & Johnson

Sean Nolan
Chief Architect and General Manager, Health Solutions Group, Microsoft Corp.

P ∧ up

Dennis G. Podlesak, M.B.A.
Partner, Domain Associates

George Poste, Ph.D., D.V.M
Chief Scientist, Complex Adaptive Systems Initiative, Arizona State University

R ∧ up

Raul Rabadan, Ph.D.
Assistant Professor, Department of Biomedical Informatics, Center for Computational Biology and Bioinformatics, Columbia University College of Physicians and Surgeons

Michael Rawlins
Chairman, National Institute of Health and Clinical Excellence

Susan Rohrer, Ph.D.
Senior Director, External Scientific Affairs, Worldwide Licensing, Merck Research Laboratories

S ∧ up

Ken Schaner, J.D.
Managing Partner, Schaner & Lubitz

Wendy Selig, M.S.
President and CEO, Melanoma Research Alliance

Sebastian Seung, Ph.D.
Professor of Computational Neuroscience, MIT; author of Connectome: How the Brain's Wiring Makes Us Who We Are

Padmanee Sharma, M.D., Ph.D.
Associate Professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center

Todd Sherer, Ph.D.
Chief Executive Officer, Michael J. Fox Foundation for Parkinson's Research

Jeffrey Shuren, M.D., J.D.
Director, Center for Devices and Radiological Health, U.S. Food and Drug Administration

Ellen V. Sigal, Ph.D.
Chair and Founder, Friends of Cancer Research

Greg Simon, J.D.
Senior Vice President, Patient Engagement, Pfizer Inc.

Josh Sommer
Executive Director, Chordoma Foundation

Stephen P. Spielberg, MD, PhD
Deputy Commissioner for Medical Products and Tobacco, U.S. Food and Drug Administration

David Steinberg
Partner, PureTech Ventures

Melissa Stevens
Director of Strategic Initiatives, FasterCures

Brent Stockwell, Ph.D.
Associate Professor, Biological Science, Columbia University

T ∧ up

Jeffrey M. Trent, Ph.D., FACMG
President and Research Director, Van Andel Research Institute; President and Research Director, The Translational Genomics Research Institute (TGen)

Reed Tuckson, M.D.
Executive Vice President and Chief of Medical Affairs, UnitedHealth Group

U ∧ up

Steve Usdin
Senior Editor (Washington), BioCentury

V ∧ up

Chris Varma, Ph.D.
Entrepreneur-in-Residence, Third Rock Ventures

George Vradenburg, J.D.
Chairman, USAgainstAlzheimer's

W ∧ up

Scott J. Weir, Pharm.D., Ph.D.
Director, Institute for Advancing Medical Innovation, University of Kansas Cancer Center

Timothy M. Wright, M.D.
Global Head of Translational Sciences, Novartis Institutes for BioMedical Research (NIBR)


© 2012 Partnering for Cures \| Terms Of Use \| Privacy Statement